Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp rug-eluting stents (DES) have dramatically reduced the in-stent restenosis (ISR) rates by suppressing neo-intimal hyperplasia. 1,2 However, the complications of DES and safety concerns such as stent thrombosis (ST) have been widely publicized. 3,4
KIM U et al.
consecutive patients underwent PCI with DES at the Inje University Busan Paik Hospital. All the patients were recommended to undergo angiographic follow-up at 6 to 8 months (the 1 st angiographic follow-up), which was performed in 1,146 patients. Among the latter patients, the 2 nd angiography follow-up at 28-36 months after the post index PCI was recommended for all the living followed-up patients with DES for evaluating the complications of DES such as a CAA, and 331 lesions of 251 patients were enrolled. At the 1 st angiographic follow-up, the patients with ISR or additional intervention were excluded.
The patients with a CAA detected during the initial or the latter follow-up coronary angiography (CAG) or at the time of adverse events were grouped and compared to those patients without a CAA. The clinical outcomes of the patients with CAA were assessed from the time of the index PCI to the detection of CAA. The DES that were used included the Sirolimus-eluting stents (SES; Cypher, Cordis, J&J, Roden, The Netherlands) and the Paclitaxel-eluting stents (PES; Taxus, BSC, Natick, MA, USA). This study was approved by the local Institutional Review Board and is in accordance with the Declaration of Helsinki. Informed consent was obtained from all patients.
Procedures and Medications
All the interventions were performed according to the current standard guidelines; the interventional strategy, including the use of periprocedural glycoprotein IIb/IIIa inhibitor and intravascular ultrasound (IVUS), was left to the discretion of the operator. The patients were prescribed aspirin and clopidogrel. A loading dose of clopidogrel (300 mg or 600 mg) was given to the patients without pretreatment. The patients were strongly advised to maintain their life-long aspirin therapy. Prior to October 2006, the patients who received the SES were prescribed clopidogrel for 3 or 6 months depending on the complexity of the procedure, whereas the patients treated with the PES were given a 6-month clopidogrel prescription. After that time point, all the patients were prescribed clopidogrel for 1 year.
Study Endpoints and Definitions
CAA was defined as a localized dilatation exceeding 1.5 times 
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the diameter of the adjacent proximal normal artery segment at follow-up angiography, and this CAA was closely related to the underlying DES or its edges, and the localized dilation was absent immediately after the procedure (Figure) . 13, 14 The major adverse cardiac events (MACE), including cardiac death, myocardial infarction (MI), ischemia-driven target-vessel revascularization (TVR) and ST, were recorded. MI was defined as elevation of the creatine kinase concentrations to twice the upper limit of normal with a rise in the myocardial-bound creatine kinase fraction concentration, chest pain lasting ≥30 min or the appearance of new electrocardiographic changes. Ischemia-driven TVR was defined as emergency or elective coronary artery bypass graft or repeat PCI in the target vessel for chest pain or a positive test for ischemia (exercise stress test, stress echocardiogram, 24-h Holter monitoring, resting electrocardiogram evidence of ST-segment depression or elevation in >1 lead or a radionuclide study showing a reversible defect). Angiographic restenosis was defined as a ≥50% diameter stenosis within the target lesion. ST was classified by the Academic Research Consortium definition 15 as definite, probable, or possible and as acute (0 to 24 h), subacute (>24 h to 30 days), late (>30 days to 1 year) or very late (>1 year). ST was defined as (1) definite: an acute coronary syndrome with angiographic documentation of either vessel occlusion or thrombus within or adjacent to a previously successfully stented vessel or 
Quantitative Coronary Analysis (QCA)
Intracoronary nitroglycerin (0.2 mg) was given before and after each intervention to achieve maximal vasodilatation. QCA was performed immediately before and after DES implantation, and also during the 1 st and 2 nd angiographic follow-up CAG after the index PCI, by an experienced technician who was blinded to the type of the stent deployed. Close attention was given to discriminate between stent edge dissections and stent edge injury at the acute vessel bends during vessel movement. The angiographic measurements included proximal, distal reference diameters, the minimum lumen diameter, the percentage of lesion stenosis and the lesion length. Quantitative coronary angiographic analysis was performed using the computer-assisted automated edge detection method (CAAS II, Pie Medical BV, Maastricht, The Netherlands) at the angiography analysis core laboratory at the Inje University Busan Paik Hospital. The angiographic analysis was done for the lesion site and the treated region (the stent area covered with a DES and the adjacent (5 mm) vessel segments on each side).
Statistical Analysis
The data was expressed as mean ± SD for continuous variables, and as frequencies for the categorical variables. A 2tailed Student's test was used to assess the differences between continuous variables. The chi-square ( χ2 ) test was used for comparison of categorical variables. For multiple logistic regression, a forward stepwise method was used to detect independent predictors of CAA, variables in Tables 1, 2 and 3 with P<0.05 were entered into the analysis. The following variables were tested: the left anterior descending coronary artery location, infarct-related artery (IRA), bifurcation lesion, chronic total occlusion (CTO), the pre-Thrombolysis In Myocardial Infarction (TIMI) score, a lesion length ≥33 mm and an overlapping stent. A probability value <0.05 with 2 tails was considered significant. The data was analyzed with SAS 9.1.3. (SAS Institute Inc, Cary, NC, USA).
Results
A CAA was detected in 35 patients with 35 lesions (35/331, 10.5%). Most of the 35 lesions were found at the 2 nd angiographic follow-up after the index PCI, which shows no luminal abnormality at the 1 st angiographic follow-up; however, only 5 lesions were detected during the 1 st angiographic follow-up.
The baseline characteristics of the patients are presented in Table 1 , and they showed no significant differences between the 2 groups. Table 2 shows the angiographic characteristics of the patients; the patients with a CAA had a greater predominance of lesion in the left anterior descending artery (LAD), a lesion in an IRA, a lesion at a bifurcation and a lesion in a CTO than patients without CAA. In terms of procedural outcomes (Table 3) , the patients with CAA had slower pre-TIMI flow than those without it. A SES was used in 294 lesions and a PES was used in 36 lesions. Overlapping stents were used in 40% of the patients with a CAA (P=0.051). The QCA measurements of the lesions are shown in Table 3 , and except for the lesion length (33.3±26.9 in the patients with a CAA vs. 26.9±14.8 in the patients without it, P=0.024), there were no significant differences between the 2 groups. On univariate analysis, CAA was associated with a lesion in the LAD (P=0.001), a lesion in an IRA (P=0.013), a lesion length >33 mm (P=0.02), a lesion at a bifurcation (P=0.006), a lesion at an artery with CTO (P=0.009), a site with overlapping (P=0.051). On multivariate analysis, a lesion in IRA Table 4 ). Table 5 shows the diagnostic characteristics of the patients with a detected CAA and MACE. By angiography, the mean maximal diameter was 4.7±0.9 mm. Most aneurysms were located in the proximal third (37.1%) and middle (45.7%) of the DES segment. The saccular type of CAA was detected for 25 lesions (71.4%), the fusiform type was detected for 8 lesions (22.9%) and the mixed type was detected for 2 lesions (5.7%). ISR was observed in 9 patients (25.7%). Although most patients were asymptomatic (71.4%, 25/35), 2 patients were presented as stable angina (5.7%, 2 patients). However, 8 patients (22.9%) presented with acute coronary syndrome (3 patients with unstable angina, 3 patients with ST-elevation MI [STEMI] and 2 patients with non-STEMI). Eight patients were treated by balloon angioplasty and another stent was implanted in 2 patients. Medical treatment with dual antiplatelet agents, including aspirin and clopidogrel, was indefinitely applied after discharge to all the patients who previously had a CAA.
The MACE are shown in Table 5 . The mean follow-up duration was 1,046±516 days. MI was found in 5 patients (14.3%) and TVR in 10 patients (28.6%). There were no deaths. MACE were observed in 10 patients (28.6%). ST occurred in 5 patients (14.3%). All the ST occurred over 1 year (very late ST) after the index PCI and the patients were continued on their medication without skipping. All thrombi were observed in the site of aneurysm.
Discussion
The major findings of this study are the independent risk factors for developing a CAA after implantation of DES, and these included lesion in the LAD location, a lesion with CTO, a lesion length ≥33 mm and lesion in an IRA; most of the aneurysms were detected ≥1 year after the index procedure. Most of the CAA remained asymptomatic; however, 28.6% of the patients with a CAA were associated with adverse clinical events, and especially MI due to ST.
The exact incidence of CAA that develops after DES implantation is unknown; the incidence rate for PES compared with bare metal stents (BMS) was 1.4% vs. 0.2% in the TAXUS V study, 16 while in a study by Alfonso et al, 13 the incidence rates of CAA was 1.25% at repeated angiographic evaluation.
Our study showed that the incidence of CAA was roughly 1.7% (35 in 2,011 patients), although all the patients with a DES were not followed up by angiography. Our study showed that most of the CAA cases were detected at ≥1 year after the post index PCI; only 5 cases (0.43%, 5/1,146) were detected at the first angiographic follow-up before 1 year. However, during the second angiographic follow-up at 32-36 months after the index PCI, 30 patients with CAA were discovered. These observations might reflect the effects of delayed healing and sustained inflammation that have been suggested to occur with a DES. In practice, we have a tendency not to perform angiography again after the first angiographic follow-up unless prompted to do so by adverse events. From the results of this study, longer-term angiographic follow-up in patients with DES, and especially more than 1 year after the index PCI, is important for assessing and detecting potentially harmful complications such as a CAA, which might be the cause of ST.
Although this study had a small population of participants and it was a single center study, we detected a higher incidence of CAA than did the previous reports. This might be because we performed long-term serial angiographic followup of nearly 3 years after the index PCI. Longer term angiographic follow-up might have enabled us to detect more complications of DES.
The development of a CAA after coronary intervention was reported to be a consequence of the residual dissection and deep arterial wall injury caused by oversized balloons or stents, high-pressure balloon inflations, atherectomy and laser angioplasty. 5-7, 14 However, a DES adds other potential mechanisms such as local drug delivery by the polymer/drug 
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coating that leads to an altered vessel wall environment, and this might affect the formation of a CAA by delayed reendothelialization, sustained inflammatory changes in the vessel wall and hypersensitivity reactions. 17,18-20 An intransient eosinophilic infiltrate, thrombosis and lack of intimal healing have been identified in autopsied patients with DES implantation, and there was no evidence of hypersensitivity reaction to a BMS. 10, 21 These findings were similar to those of the CAA associated with DES, and DES have been suggested to possibly be related with ST. The clinical implications of CAA were previously unknown, but we found 5 ST when detecting the CAA. The CAA that developed from the sources mentioned might be closely linked with clinically dangerous late ST. We elucidated several risk factors for a CAA after DES implantation. These risk factors were similar to those of late-acquired malapposition. 22-25 The latter findings also suggest that late-acquired malapposition can be another mechanism of CAA, and it might also be related with ST. Incomplete stent apposition (ISA) is defined as one or more struts clearly separated from the vessel wall with evidence of blood speckle behind the strut in a segment not associated with any side branches. 26 Late acquired ISA primarily results from structural vessel wall changes that occur during the follow-up period. 26 Positive vascular remodeling and/or dissolution of thrombus has been recognized as the most likely mechanisms of late acquired ISA. 27 We already described that CAA was defined as a localized dilatation exceeding 1.5 times the diameter of the adjacent proximal normal artery segment. It seems that CAA developed after PCI and late acquired ISA were based on the same mechanism but their size was different. Although 2 conditions seemed to have basically the same disease category, CAA was big enough to detect by CAG, but in the case of late acquired ISA, it is detected by IVUS or optical coherence tomography. 26, 28 We assumed that CAA and late acquired ISA seem to have the same disease process. At first, late acquired ISA is supposed to be made due to positive vascular remodeling. Persistent inflammation and hypersensitivity reaction of DES itself might affect the vessel wall and this can lead to develop CAA. This study had several limitations. First, this was a singlecenter's experience with CAA assessment. Second, this study was not a prospective randomized trial and 2 angiographic follow-ups in all the patients with DES were not done after the index PCI. Therefore, the populations we investigated might have been heterogeneous. The influence of a selection and treatment bias cannot be ruled out. During the study period, although all the investigators recommended first and second angiographic follow-up to all the consecutive patients receiving DES, a considerable number of patients could not be analyzed because they refused to participate in this study due to absence of their symptoms. However, we enrolled all possible consecutive patients in the follow-up angiography to minimize this limitation. We admit that a prospective trial is the only method to minimize the chance of selection bias. Third, the study size might appear relatively small to assess CAA, yet compared with the previous studies that reported on the incidence rates of CAA, our sample size was relatively modest. Fourth, imaging studies such as IVUS was not performed in all patients, which might have prevented evaluating the mechanisms of CAA such as late-acquired ISA.
In conclusion, the patients with DES implantation into lesions longer than 33 mm, a lesion located in the LAD, a lesion with CTO and a lesion in an IRA were closely followed up for over 1 year after the index procedure. Although most of the patients remained asymptomatic, 28.6% had unfavorable clinical outcomes. Further large clinical trials and follow-up studies are needed for better understanding this complication.
